Drug intelligence / Profile preview

Tribestan

Development stage
Unknown
Lead developer
Sopharma
Modality
Small Molecules
Administration
Oral
01

Overview

Tribestan is a natural, non-hormonal herbal (phytochemical) small molecule drug/supplement developed and manufactured by Sopharma PLC. Its active ingredients are protodioscin and protogracillin — furostanol-type saponins extracted from the aerial parts of the Bulgarian *Tribulus terrestris* L. plant. The drug is formulated as 250 mg film-coated oral tablets. Tribestan's proposed mechanism involves stimulation of endogenous testosterone production (acting on the hypothalamic-pituitary-gonadal axis) rather than direct hormonal activity, classifying it as a non-hormonal biostimulator. It is indicated for erectile dysfunction (ED), hypoactive sexual desire disorder (HSDD) in men, male infertility, and dyslipoproteinemia (reduction of total cholesterol and LDL). It has also been used in women for climacteric and postcastration syndrome.

Brand names
Tribestan
Other names
Tribulus terrestris extractBulgarian Tribulus terrestris extract
02

Targets

LHCGR (Luteinizing hormone/choriogonadotropin receptor)

Beyond the preview

Go deeper on Tribestan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tribestan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call